Skip to main content

Praxis Precision Medicines Inc (PRAX) Stock

Praxis Precision Medicines Inc Stock Details, Movements and Public Alerts

Stock Details

Praxis Precision Medicines Inc (PRAX), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $268.95. Over the past 52 weeks, it has ranged between $26.70 and $286.50. This places the current price at 93.9% of its 52-week high and 907.3% above its 52-week low. Recent trading volume was recorded at 251,499. The 14-day Relative Strength Index (RSI) stands at 64.51, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $208.64 by 28.91%. Similarly, it is above its 200-day moving average of $84.89 by 216.82%. The MACD histogram is -1.48, indicating bearish momentum (MACD Line: 24.32, Signal Line: 25.80). There is currently 1 active alert set for PRAX by users.

52-Week Range

$286.50 - $26.70

-6.13% from high · +907.30% from low

Avg Daily Volume

825,899

20-day average

100-day avg: 819,762

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

20.00

EV/EBITDA

-6.86

EPS (TTM)

-$12.97

Price to Sales

920.67

Beta

2.98

More volatile than market

Q:How is PRAX valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is PRAX's risk profile compared to the market?
With a beta of 2.98, Praxis Precision Medicines Inc is significantly more volatile than the market. For every 10% market move, this stock tends to move 30% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 20.00 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-3928.00%

EBITDA

$-292,951,008

Return on Equity

-75.20%

Return on Assets

-45.10%

Revenue Growth (YoY)

1349.00%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is PRAX's business model?
0 The operating margin of -3928.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -75.20% and ROA at -45.10%, the company achieves moderate returns on invested capital.
Q:What are PRAX's recent growth trends?
Praxis Precision Medicines Inc's revenue grew by 1349.00% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends.0 These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Market Cap

$6.9B

Revenue (TTM)

$7.46M

Revenue/Share (TTM)

$0.35

Shares Outstanding

25.01M

Book Value/Share

$16.23

Asset Type

Common Stock

Q:What is PRAX's market capitalization and position?
Praxis Precision Medicines Inc has a market capitalization of $6.9B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 25.01M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
Q:How does PRAX's price compare to its book value?
Praxis Precision Medicines Inc's book value per share is $16.23, while the current stock price is $268.95, resulting in a price-to-book (P/B) ratio of 16.57. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$419.13

55.84% upside potential

Analyst Recommendations

Strong Buy

2

Buy

12

Hold

0

Sell

1

Strong Sell

0

Q:How reliable are analyst predictions for PRAX?
15 analysts cover PRAX with 93% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $419.13 implies 55.8% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on PRAX?
Current analyst recommendations:2 Strong Buy, 12 Buy, 01 Sell, 0The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Dec 27, 2025, 02:02 AM

Technical Indicators

RSI (14-day)

64.51

Neutral

50-Day Moving Average

$208.64

28.91% above MA-50

200-Day Moving Average

$84.89

216.82% above MA-200

MACD Line

24.32

MACD Signal

25.80

MACD Histogram

-1.48

Bearish

Q:What does PRAX's RSI value tell investors?
The RSI (Relative Strength Index) for PRAX is currently 64.51, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret PRAX's MACD and moving average crossovers?
MACD analysis shows the MACD line at 24.32 below the signal line at 25.80, with histogram at -1.48. This bearish crossover indicates downward pressure. The wide histogram confirms strong momentum. The 50-day MA ($208.64) is above the 200-day MA ($84.89), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Dec 27, 2025, 12:34 AM

Active Alerts

Alert Condition
Price decreases by
Threshold
10%
Created
Nov 27, 2025, 04:05 PM

Stay Ahead of the Market with Praxis Precision Medicines Inc Alerts

Set up price alerts for Praxis Precision Medicines Inc and get notified instantly when the price hits your target. Never miss an important price movement again.